Ad is loading...
LMNOX
Price
$43.28
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
VSEMX
Price
$243.84
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

LMNOX vs VSEMX

Header iconLMNOX vs VSEMX Comparison
Open Charts LMNOX vs VSEMXBanner chart's image
Patient Opportunity I
Price$43.28
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Extended Market Index Instl Sel
Price$243.84
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
LMNOX vs VSEMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LMNOX vs. VSEMX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMNOX is a StrongSell and VSEMX is a Buy.

FUNDAMENTALS
Fundamentals
VSEMX has more cash in the bank: 107B vs. LMNOX (1.61B). VSEMX pays higher dividends than LMNOX: VSEMX (1.23) vs LMNOX (0.00). LMNOX was incepted earlier than VSEMX: LMNOX (24 years) vs VSEMX (8 years). LMNOX is a more actively managed with annual turnover of: 40.00 vs. VSEMX (11.00). LMNOX has a lower initial minimum investment than VSEMX: LMNOX (1000000) vs VSEMX (3000000000). LMNOX annual gain was more profitable for investors over the last year : 48.88 vs. VSEMX (36.80). VSEMX return over 5 years is better than : 66.91 vs. LMNOX (44.16).
LMNOXVSEMXLMNOX / VSEMX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years8 years-
Gain YTD29.07821.965132%
Front LoadN/AN/A-
Min. Initial Investment100000030000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.61B107B2%
Annual Yield % from dividends0.001.23-
Returns for 1 year48.8836.80133%
Returns for 3 years-4.765.34-89%
Returns for 5 years44.1666.9166%
Returns for 10 years109.83N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LFMD5.690.27
+4.98%
LifeMD
CULP5.090.13
+2.62%
Culp
SFM145.893.14
+2.20%
Sprouts Farmers Market
GILD89.761.13
+1.27%
Gilead Sciences
VCYT38.94-0.26
-0.66%
Veracyte